Tag: sexually transmitted infections market trends

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theSexually Transmitted Infections (STIs) Market?

The rise in governmental efforts to increase awareness about sexually transmitted infections is predicted to fuel the growth of the sexually transmitted infections (STIs) market. Government initiatives are designed to tackle specific issues and accomplish certain objectives. Governments implement various schemes to tackle sexually transmitted infections (STIs), including funding for mass education programs to increase STI awareness, vaccines to ward off specific STIs, and free or affordable screening and testing. For example, in April 2023, the US-based Springfield-Greene County Health department announced a new program called Disease Intervention Specialist (DIS), in partnership with the Missouri Department of Health and Senior Services (Missouri DHSS). This initiative aimed at curbing the escalating spread of sexually transmitted infections (STIs) in Greene County. The primary focus of the two specialists in the DIS program is on syphilis and HIV. They assist those who test positive for these diseases, linking them with treatment options and identifying others potentially affected. Thus, the rise in governmental initiatives is anticipated to bolster the sexually transmitted infections (STIs) market. The escalating trend of unprotected sex is another driving factor expected to stimulate the sexually transmitted infections (STIs) market. This growing trend refers to the increasing number of individuals engaging in sexual acts without any protective measures such as condoms, leading to the spread of sexually transmitted diseases (STIs). For instance, in August 2024, the World Health Organization, a UK-based intergovernmental body, reported a drop in condom use in 2022, with only 61% of sexually active boys and 57% of girls using protection during their most recent intercourse, down from 70% and 63%, respectively. Thus, the growing trend of unprotected sex is enhancing the sexually transmitted infections (STIs) market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

#What Long-Term Growth Rate is Expected for theSexually Transmitted Infections (STIs) Market Between 2025 and 2034?

The market size for sexually transmitted infections (STIs) has seen substantial growth over the past few years. Its value is predicted to rise from $63.69 billion in 2024, reaching $71.93 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors driving this growth during the historic period include changes in behavior, educational initiatives, increased awareness, improved healthcare access, and advancements in antibiotic development.

In the upcoming years, there is an anticipated significant expansion in the market size of sexually transmitted infections (STIs), with predictions reaching up to $113.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. The expected growth during this forecasted period is due to the emergence of new STIs strains, vaccination programs, telemedicine, at-home testing, and sexual health equity. The substantial trends within this period are expected to be the increase in antimicrobial resistance, the rise of pre-exposure prophylaxis (prep), STIs self-management, and improved sexual education.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

What Are the Latest Innovations Influencing theSexually Transmitted Infections (STIs) Market?

Leading corporations in the sexually transmitted infections (STIs) industry are capitalizing on fluorescent PCR (Polymerase Chain Reaction) technology to create forward-thinking products, thereby securing a competitive edge in the marketplace. Fluorescent PCR technology is a method in molecular biology that identifies and measures certain DNA sequences within a biological specimen. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions company based in China, unveiled two new PCR kits named Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These kits provide a comprehensive PCR solution for the early detection of STIs, affecting myriad individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit, a reagent utilizing fluorescent PCR technology, is able to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. In addition, the BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to uncover treponema pallidum nucleic acid in human serum and plasma.

Who Are the Major Industry Players Accelerating Growth in theSexually Transmitted Infections (STIs) Market?

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Which Primary Segments of the Sexually Transmitted Infections (STIs) Market Are Driving Growth and Industry Transformations?

The sexually transmitted infections (STIs) market covered in this report is segmented –

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theSexually Transmitted Infections (STIs) Market?# Market?

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2025, By The Business Research Company:

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the sexually transmitted infections (stis) market?

The sexually transmitted infections (STIs) market has seen significant growth, with expectations to expand from $63.69 billion in 2024 to $71.93 billion in 2025 at a CAGR of 12.9%. Historical drivers of growth include behavioral patterns, education and awareness efforts, improved healthcare access, and advancements in antibiotic development.

What will be the sexually transmitted infections (stis) market size in the future?

The sexually transmitted infections (STIs) market is projected to expand rapidly, reaching $113.38 billion in 2029 at a 12.0% CAGR. Growth is driven by emerging STI strains, vaccination initiatives, and increased accessibility to telemedicine and at-home testing. Trends include antimicrobial resistance monitoring, expansion of pre-exposure prophylaxis (PrEP), and enhanced sexual education efforts.

Get your sexually transmitted infections (stis) market report here!

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

What main drivers are fueling expansion in the sexually transmitted infections (stis) market?

Boosted efforts from various government establishments to raise consciousness about sexually transmitted infections (STIs) are anticipated to stimulate the growth of the STIs market. An initiative by the government is a specific project or policy put in place in order to achieve a determined objective or address particular issues. The administration offers numerous initiatives to curb, manage, and treat STIs. These strategies vary from funds apportioned for public education campaigns aimed at raising awareness about STIs, to providing vaccines for the prevention of specific STIs, and offering free or economical screenings and tests. In a notable instance, Springfield-Greene County Health, a public health department based in the US, rolled out a fresh program named Disease Intervention Specialist (DIS) in collaboration with the Missouri Department of Health and Senior Services. Introduced in April 2023, this initiative was launched to counter the growing prevalence of STIs in Greene County. The pair of experts heading the DIS initiative, with a specific focus on syphilis and HIV, are tasked with reaching out to those testing positive for these diseases, linking them with viable treatment options and helping identify and communicate with them to make them aware of their infection. Therefore, the escalated government initiatives are anticipated to act as a catalyst for the growth of the STIs market. An escalating prevalence of unprotected sex could potentially drive the growth of the sexually transmitted infections (STIs) market. The rising trend of unprotected sex denotes a practice of engaging in sexual activities without the use of protection, like condoms, which can lead to the transmission of sexually transmitted diseases (STIs). An example being in August 2024, the World Health Organization, an intergovernmental organization based in the UK, reported that in 2022 there was a decline in the percentage of sexually active adolescents using condoms during their most recent sexual act, with 61% of boys and 57% of girls reporting the use of condoms. This was a notable dip from the previously reported 70% and 63%, respectively. Therefore, the increasing prevalence of unprotected sex is serving to drive the sexually transmitted infections (STIs) market.

What key areas define the segmentation of the global sexually transmitted infections (stis) market?

The sexually transmitted infections (STIs) market covered in this report is segmented –

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

Who are the dominant players expanding their reach in the sexually transmitted infections (stis) market?

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

How are evolving market trends shaping sexually transmitted infections (stis) Strategies?

Major players in the sexually transmitted infections (STIs) market are leveraging cutting-edge fluorescent PCR technology to develop novel products, in an effort to achieve a competitive edge. The Fluorescent PCR (Polymerase Chain Reaction) mechanism is a molecular biology procedure that identifies and measures specific DNA sequences within a biological specimen. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions provider from China, unveiled two new polymer chain reaction (PCR) kits: Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These kits present a comprehensive PCR solution for the early detection of sexually transmitted diseases, affecting numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent applying fluorescent PCR technology to discover Mycoplasma hominis in specimens such as male urethral swabs, female cervical or vaginal swabs, and urine. In a similar vein, the BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to identify treponema pallidum nucleic acid in human serum and plasma.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

Which regions are emerging as leaders in the sexually transmitted infections (stis) market?

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Future CAGR of the Sexually Transmitted Infections (STIs) Market, and How Will It Impact Industry Expansion?

There has been a swift expansion in the market size of sexually transmitted infections (STIs) in the recent past. The market is projected to escalate from $63.69 billion in 2024 to $71.93 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.9%. The growth during the historic period can be traced back to factors such as behavioral changes, educational initiatives, increased awareness, enhanced healthcare access, and the development of antibiotics.

The market size for sexually transmitted infections (STIs) is predicted to experience fast expansion in the upcoming years, with an expected worth of $113.38 billion by 2029 and a compound annual growth rate of 12.0%. Factors contributing to this growth during the forecast period include the emergence of new STIs strains, vaccine initiatives, telemedicine, home-based testing, and sexual health equity. Furthermore, critical trends during the prediction period consist of increasing antimicrobial resistance, pre-exposure prophylaxis (prep), self administered STIs treatment, and improved sexual education.

What External and Internal Drivers Are Contributing to the Growth of the Sexually Transmitted Infections (STIs) Market’s Growth?

Boosted efforts from various government establishments to raise consciousness about sexually transmitted infections (STIs) are anticipated to stimulate the growth of the STIs market. An initiative by the government is a specific project or policy put in place in order to achieve a determined objective or address particular issues. The administration offers numerous initiatives to curb, manage, and treat STIs. These strategies vary from funds apportioned for public education campaigns aimed at raising awareness about STIs, to providing vaccines for the prevention of specific STIs, and offering free or economical screenings and tests. In a notable instance, Springfield-Greene County Health, a public health department based in the US, rolled out a fresh program named Disease Intervention Specialist (DIS) in collaboration with the Missouri Department of Health and Senior Services. Introduced in April 2023, this initiative was launched to counter the growing prevalence of STIs in Greene County. The pair of experts heading the DIS initiative, with a specific focus on syphilis and HIV, are tasked with reaching out to those testing positive for these diseases, linking them with viable treatment options and helping identify and communicate with them to make them aware of their infection. Therefore, the escalated government initiatives are anticipated to act as a catalyst for the growth of the STIs market. An escalating prevalence of unprotected sex could potentially drive the growth of the sexually transmitted infections (STIs) market. The rising trend of unprotected sex denotes a practice of engaging in sexual activities without the use of protection, like condoms, which can lead to the transmission of sexually transmitted diseases (STIs). An example being in August 2024, the World Health Organization, an intergovernmental organization based in the UK, reported that in 2022 there was a decline in the percentage of sexually active adolescents using condoms during their most recent sexual act, with 61% of boys and 57% of girls reporting the use of condoms. This was a notable dip from the previously reported 70% and 63%, respectively. Therefore, the increasing prevalence of unprotected sex is serving to drive the sexually transmitted infections (STIs) market.

Explore Comprehensive Insights Into The Global Sexually Transmitted Infections (STIs) Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

What Are the Top Market Players Propelling the Growth of the Sexually Transmitted Infections (STIs) Industry?

Major companies operating in the sexually transmitted infections (stis) market are:

• Pfizer Inc._x000D_

• Johnson & Johnson_x000D_

• Roche Holdings AG_x000D_

• Merck & Co Inc._x000D_

• AbbVie Inc._x000D_

What Are the Key Trends to Watch in the Sexually Transmitted Infections (STIs) Market Over the Coming Years?

Major players in the sexually transmitted infections (STIs) market are leveraging cutting-edge fluorescent PCR technology to develop novel products, in an effort to achieve a competitive edge. The Fluorescent PCR (Polymerase Chain Reaction) mechanism is a molecular biology procedure that identifies and measures specific DNA sequences within a biological specimen. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions provider from China, unveiled two new polymer chain reaction (PCR) kits: Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These kits present a comprehensive PCR solution for the early detection of sexually transmitted diseases, affecting numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent applying fluorescent PCR technology to discover Mycoplasma hominis in specimens such as male urethral swabs, female cervical or vaginal swabs, and urine. In a similar vein, the BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to identify treponema pallidum nucleic acid in human serum and plasma.

Secure Your Global Sexually Transmitted Infections (STIs) Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Sexually Transmitted Infections (STIs) Market?

The sexually transmitted infections (STIs) market covered in this report is segmented –

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

What Regions Are Dominating the Sexually Transmitted Infections (STIs) Market Growth?

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Do Experts Define the Scope of the Sexually Transmitted Infections (STIs) Market?

Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact.

Browse Through More Similar Reports By The Business Research Company:

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: